Egyptian-American fund announces new pharmaceutical investment

EGYPT TODAY STAFF | November 7, 2017

article image
The Egyptian-American Enterprise Fund (EAEF) signed an agreement to acquire a minority stake in Orchidia Pharmaceutical Industries, the company announced in a statement earlier this week.

Spotlight

Life Healthcare

The Life Healthcare Group is a key role-player in the South African healthcare sector and is listed on the Johannesburg Stock Exchange (JSE). Our primary business is private acute hospital care. With 63 healthcare facilities, our group has one of the most extensive footprints in southern Africa. Life Healthcare is the first and only hospital group to have achieved multi-site ISO 9001 certification. Our international division includes the Group’s investment in Max Healthcare, an acute care hospital business in India and Scanmed Multimedis, a leading healthcare provider in Poland.

OTHER ARTICLES

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

Life Healthcare

The Life Healthcare Group is a key role-player in the South African healthcare sector and is listed on the Johannesburg Stock Exchange (JSE). Our primary business is private acute hospital care. With 63 healthcare facilities, our group has one of the most extensive footprints in southern Africa. Life Healthcare is the first and only hospital group to have achieved multi-site ISO 9001 certification. Our international division includes the Group’s investment in Max Healthcare, an acute care hospital business in India and Scanmed Multimedis, a leading healthcare provider in Poland.

Events